| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1030823077 |
| P356 | DOI | 10.1186/2001-1326-1-2 |
| P932 | PMC publication ID | 3552569 |
| P698 | PubMed publication ID | 23369602 |
| P5875 | ResearchGate publication ID | 235390460 |
| P2093 | author name string | Sarbelio Rodríguez Muñoz | |
| Luis Madero | |||
| Elena López | |||
| Juan López Pascual | |||
| P2860 | cites work | Large-scale characterization of HeLa cell nuclear phosphoproteins | Q24300834 |
| Investigation of protein-tyrosine phosphatase 1B function by quantitative proteomics | Q24318475 | ||
| Analysis of phosphorylation sites on proteins from Saccharomyces cerevisiae by electron transfer dissociation (ETD) mass spectrometry | Q24671750 | ||
| Identification of a novel immunoreceptor tyrosine-based activation motif-containing molecule, STAM2, by mass spectrometry and its involvement in growth factor and cytokine receptor signaling pathways | Q28138981 | ||
| Quantitative phosphoproteome analysis using a dendrimer conjugation chemistry and tandem mass spectrometry | Q28266730 | ||
| Proposal for a common nomenclature for sequence ions in mass spectra of peptides | Q28269961 | ||
| Rapid detection of antibodies in sera using multiplexed self-assembling bead arrays | Q28384360 | ||
| Annexins: from structure to function | Q29616171 | ||
| Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae | Q29618445 | ||
| Contributions of mass spectrometry to peptide and protein structure | Q30403592 | ||
| A neutral loss activation method for improved phosphopeptide sequence analysis by quadrupole ion trap mass spectrometry | Q30433863 | ||
| MALDI imaging mass spectrometry of human tissue: method challenges and clinical perspectives | Q30470146 | ||
| Graphite powder as an alternative or supplement to reversed-phase material for desalting and concentration of peptide mixtures prior to matrix-assisted laser desorption/ionization-mass spectrometry | Q30859368 | ||
| Advances in proteomic strategies toward the early detection of lung cancer | Q31008766 | ||
| Highly selective enrichment of phosphorylated peptides from peptide mixtures using titanium dioxide microcolumns. | Q31164900 | ||
| Chemical derivatization of phosphoserine and phosphothreonine containing peptides to increase sensitivity for MALDI-based analysis and for selectivity of MS/MS analysis | Q33230138 | ||
| Next-generation high-density self-assembling functional protein arrays | Q33333441 | ||
| Microfluidic chips for mass spectrometry-based proteomics | Q33431346 | ||
| Multiplexed Cell Signaling Analysis of Metastatic and Nonmetastatic Colorectal Cancer Reveals COX2-EGFR Signaling Activation as a Potential Prognostic Pathway Biomarker | Q33441095 | ||
| Multiplexed microbead immunoassays by flow cytometry for molecular profiling: Basic concepts and proteomics applications | Q33465218 | ||
| The potential of optical proteomic technologies to individualize prognosis and guide rational treatment for cancer patients | Q33503737 | ||
| A glycomics approach to the discovery of potential cancer biomarkers | Q33514448 | ||
| A proteomic approach for plasma biomarker discovery with iTRAQ labelling and OFFGEL fractionation | Q33514848 | ||
| Profiling carbonylated proteins in human plasma | Q33528052 | ||
| Peptide and protein imaging mass spectrometry in cancer research | Q33590307 | ||
| In situ proteomic analysis of human breast cancer epithelial cells using laser capture microdissection: annotation by protein set enrichment analysis and gene ontology | Q33672680 | ||
| Initial development and validation of a novel extraction method for quantitative mining of the formalin-fixed, paraffin-embedded tissue proteome for biomarker investigations | Q33758692 | ||
| To cycle or not to cycle: a critical decision in cancer. | Q33957955 | ||
| Quadrupole time-of-flight versus triple-quadrupole mass spectrometry for the determination of phosphopeptides by precursor ion scanning | Q34085102 | ||
| Proteomics and ovarian cancer: integrating proteomics information into clinical care | Q34126627 | ||
| The evolving role of mass spectrometry in cancer biomarker discovery | Q34215422 | ||
| AKT and oxidative stress team up to kill cancer cells. | Q54782691 | ||
| Reproducible isolation of distinct, overlapping segments of the phosphoproteome | Q57205837 | ||
| Quantitative Phosphoproteomics of Early Elicitor Signaling inArabidopsis | Q57448564 | ||
| Selective enrichment of Ser-/Thr-phosphorylated peptides in the presence of Ser-/Thr-glycosylated peptides | Q57666275 | ||
| Quantitative proteomic assessment of very early cellular signaling events | Q57979684 | ||
| Head-to-Head Comparison of Serum Fractionation Techniques | Q58068945 | ||
| p38α MAP kinase is essential in lung stem and progenitor cell proliferation and differentiation | Q61776576 | ||
| A new derivatization strategy for the analysis of phosphopeptides by precursor ion scanning in positive ion mode | Q74748629 | ||
| Fragmentation of phosphopeptides in an ion trap mass spectrometer | Q77482776 | ||
| Enhanced phosphorylation of p53 serine 18 following DNA damage in DNA-dependent protein kinase catalytic subunit-deficient cells | Q78124992 | ||
| Multiplex immune serum biomarker profiling in sarcoidosis and systemic sclerosis | Q84095175 | ||
| Selective detection of phosphopeptides in complex mixtures by electrospray liquid chromatography/mass spectrometry | Q86718961 | ||
| Analysis of phosphorylated proteins and peptides by mass spectrometry | Q34386307 | ||
| Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins | Q34473545 | ||
| Analysis of protein phosphorylation using mass spectrometry: deciphering the phosphoproteome | Q34635360 | ||
| Clinical and technical phosphoproteomic research | Q35081756 | ||
| Protein Microarray Signature of Autoantibody Biomarkers for the Early Detection of Breast Cancer | Q35170389 | ||
| Discovering and validating unknown phospho-sites from p38 and HuR protein kinases in vitro by Phosphoproteomic and Bioinformatic tools | Q35189096 | ||
| Technical phosphoproteomic and bioinformatic tools useful in cancer research | Q35373413 | ||
| Global proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry. | Q35629586 | ||
| Candidate-based proteomics in the search for biomarkers of cardiovascular disease | Q35990040 | ||
| Protein phosphatases in MAPK signalling: we keep learning from yeast. | Q36258092 | ||
| Quantitative serum proteomics using dual stable isotope coding and nano LC-MS/MSMS | Q36384562 | ||
| Proteomic analysis in cancer research: potential application in clinical use. | Q36463990 | ||
| Dissection of the insulin signaling pathway via quantitative phosphoproteomics | Q36497303 | ||
| Protein biomarker discovery and validation: the long and uncertain path to clinical utility | Q36561644 | ||
| Signaling through RAS-RAF-MEK-ERK: from basics to bedside. | Q36754537 | ||
| Phosphoproteomic analysis of human brain by calcium phosphate precipitation and mass spectrometry | Q37146736 | ||
| Cell density-dependent inhibition of epidermal growth factor receptor signaling by p38alpha mitogen-activated protein kinase via Sprouty2 downregulation | Q37233356 | ||
| Phosphopeptide fragmentation and analysis by mass spectrometry | Q37510777 | ||
| Decoding signalling networks by mass spectrometry-based proteomics | Q37749492 | ||
| The annexin protein lipocortin 1 regulates the MAPK/ERK pathway | Q38317186 | ||
| Differential membrane proteomics using 18O-labeling to identify biomarkers for cholangiocarcinoma | Q38875926 | ||
| Defining central themes in breast cancer biology by differential proteomics: conserved regulation of cell spreading and focal adhesion kinase | Q39672234 | ||
| Super-SILAC mix for quantitative proteomics of human tumor tissue | Q39719028 | ||
| Systems-wide analysis of a phosphatase knock-down by quantitative proteomics and phosphoproteomics | Q39853507 | ||
| N-cadherin signaling potentiates mammary tumor metastasis via enhanced extracellular signal-regulated kinase activation | Q40149357 | ||
| Constitutive activation of MAPK/ERK inhibits prostate cancer cell proliferation through upregulation of BRCA2. | Q40201265 | ||
| Global effects of kinase inhibitors on signaling networks revealed by quantitative phosphoproteomics | Q42013412 | ||
| Systematic analysis of peptide recoveries from in-gel digestions for protein identifications in proteome studies | Q42024221 | ||
| Regulation of calcyclin (S100A6) binding by alternative splicing in the N-terminal regulatory domain of annexin XI isoforms | Q42060884 | ||
| Proteomic analysis of organ-specific post-translational lysine-acetylation and -methylation in mice by use of anti-acetyllysine and -methyllysine mouse monoclonal antibodies | Q42485737 | ||
| Extracellular signal-regulated protein kinase is activated in cervical intraepithelial neoplasms but inactivated in invasive cervical carcinoma | Q42497188 | ||
| Large scale localization of protein phosphorylation by use of electron capture dissociation mass spectrometry. | Q42804428 | ||
| Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle | Q43474246 | ||
| Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis | Q43668838 | ||
| Improved beta-elimination-based affinity purification strategy for enrichment of phosphopeptides | Q44689393 | ||
| Quantitative phosphoproteomics applied to the yeast pheromone signaling pathway | Q45234630 | ||
| Systematic analysis of the IgG antibody immune response against varicella zoster virus (VZV) using a self-assembled protein microarray | Q45375642 | ||
| Multiplexed proteomics mapping of yeast RNA polymerase II and III allows near-complete sequence coverage and reveals several novel phosphorylation sites | Q46914773 | ||
| Differential mass spectrometry: a label-free LC-MS method for finding significant differences in complex peptide and protein mixtures. | Q51635400 | ||
| [Focal nodular hyperplasia of liver: a clinicopathologic study of 238 patients]. | Q53236410 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 2 | |
| P577 | publication date | 2012-03-29 | |
| P1433 | published in | Clinical and translational medicine | Q27724586 |
| P1476 | title | Relevant phosphoproteomic and mass spectrometry: approaches useful in clinical research | |
| P478 | volume | 1 |
| Q35879468 | A proteomic approach to obesity and type 2 diabetes |
| Q36507644 | Clinical proteomics and OMICS clues useful in translational medicine research |
| Q35542665 | Enrichment of phosphorylated peptides and proteins by selective precipitation methods |
| Q39474930 | Functional phosphoproteomic mass spectrometry-based approaches |
| Q36105196 | Global comparison of chromosome X genes of pulmonary telocytes with mesenchymal stem cells, fibroblasts, alveolar type II cells, airway epithelial cells, and lymphocytes |
| Q30868595 | Large-scale label-free phosphoproteomics: from technology to data interpretation |
| Q36396425 | Phosphoproteomics and lung cancer research |
| Q26750469 | Potentials of single-cell biology in identification and validation of disease biomarkers |
| Q26861489 | Proteomics-based discovery of biomarkers for paediatric acute lymphoblastic leukaemia: challenges and opportunities |
| Q40857065 | Study of phosphorylation events for cancer diagnoses and treatment |
| Q54505379 | Using phosphoproteomics to monitor disregulated signaling networks in cardiac disease preceding heart failure. |
Search more.